Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 526 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 376-400 of 526 matching filings.

Per page
25
Current page
16
8-K File 001-38327

FORM 8-K

Filing date
07 Oct 2019
Reporting date
03 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

FORM 8-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-38327

10-Q/A

Filing date
09 Jul 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-38327

AMENDMENT NO.2 TO FORM 10-K

Filing date
09 Jul 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
21 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38327

DEFA14A

Filing date
18 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38327

DEF 14A

Filing date
18 Jun 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-229140

424B5

Filing date
05 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38327

PRE 14A

Filing date
30 May 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-38327

10-K/A

Filing date
30 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-230282

S-8

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
06 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .